HIMS & HERS HEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.88 USD | +6.63% |
|
+15.85% | +89.66% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 249 | 367.3 | 1,336 | 1,332 | 1,887 | 3,626 | - | - |
| Enterprise Value (EV) 1 | 249 | 339.9 | 1,263 | 1,284 | 1,789 | 3,409 | 3,208 | 3,626 |
| P/E ratio | -10.5 x | -63.5 x | -11.3 x | -20 x | -80.9 x | 104 x | 57.2 x | 39.1 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 3.02 x | 2.47 x | 4.91 x | 2.53 x | 2.16 x | 2.97 x | 2.37 x | 1.96 x |
| EV / Revenue | 3.02 x | 2.29 x | 4.65 x | 2.44 x | 2.05 x | 2.79 x | 2.1 x | 1.96 x |
| EV / EBITDA | - | -41.9 x | -42 x | -81.4 x | 36.1 x | 25.9 x | 17.1 x | 14 x |
| EV / FCF | - | -80.6 x | -35.8 x | -43.9 x | 31.8 x | 53.1 x | 22.7 x | - |
| FCF Yield | - | -1.24% | -2.79% | -2.28% | 3.14% | 1.88% | 4.41% | - |
| Price to Book | - | -11.6 x | 3.66 x | 4.21 x | 5.42 x | 8.63 x | 6.21 x | - |
| Nbr of stocks (in thousands) | 25,156 | 25,156 | 203,913 | 207,739 | 211,994 | 214,786 | - | - |
| Reference price 2 | 9.900 | 14.60 | 6.550 | 6.410 | 8.900 | 16.88 | 16.88 | 16.88 |
| Announcement Date | 10/23/20 | 3/18/21 | 2/22/22 | 2/27/23 | 2/26/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 82.56 | 148.8 | 271.9 | 526.9 | 872 | 1,222 | 1,529 | 1,847 |
| EBITDA 1 | - | -8.114 | -30.08 | -15.78 | 49.52 | 131.8 | 187.4 | 259.3 |
| EBIT 1 | - | -15.14 | -115 | -68.7 | -29.45 | 36.78 | 75.19 | 131.2 |
| Operating Margin | - | -10.18% | -42.31% | -13.04% | -3.38% | 3.01% | 4.92% | 7.1% |
| Earnings before Tax (EBT) 1 | - | -17.99 | -110.8 | -65.71 | -21.57 | 46.59 | 85.83 | 142.9 |
| Net income 1 | - | -18.11 | -107.7 | -65.68 | -23.55 | 39.89 | 68.5 | 98.75 |
| Net margin | - | -12.18% | -39.6% | -12.46% | -2.7% | 3.27% | 4.48% | 5.35% |
| EPS 2 | -0.9400 | -0.2300 | -0.5800 | -0.3200 | -0.1100 | 0.1624 | 0.2949 | 0.4317 |
| Free Cash Flow 1 | - | -4.216 | -35.24 | -29.24 | 56.26 | 64.25 | 141.4 | - |
| FCF margin | - | -2.83% | -12.96% | -5.55% | 6.45% | 5.26% | 9.25% | - |
| FCF Conversion (EBITDA) | - | - | - | - | 113.63% | 48.73% | 75.46% | - |
| FCF Conversion (Net income) | - | - | - | - | - | 161.05% | 206.51% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 10/23/20 | 3/18/21 | 2/22/22 | 2/27/23 | 2/26/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 84.7 | 101.3 | 113.6 | 144.8 | 167.2 | 190.8 | 207.9 | 226.7 | 246.6 | 278.2 | 295.4 | 315.6 | 334.4 | 351.4 | 366.6 |
| EBITDA 1 | -7.059 | -6.061 | -7.541 | -6.096 | 3.919 | 6.06 | 10.64 | 12.25 | 20.57 | 32.35 | 33.52 | 32.06 | 34.01 | 41.54 | 44.86 |
| EBIT 1 | -21.56 | -16.92 | -20.19 | -19.98 | -11.6 | -11.26 | -9.236 | -8.554 | -0.4 | 9.903 | 9.683 | 7.438 | 9.676 | 18.05 | 20.24 |
| Operating Margin | -25.46% | -16.7% | -17.78% | -13.8% | -6.94% | -5.9% | -4.44% | -3.77% | -0.16% | 3.56% | 3.28% | 2.36% | 2.89% | 5.14% | 5.52% |
| Earnings before Tax (EBT) 1 | -31.25 | -16.16 | -19.67 | -18.86 | -11.03 | -9.681 | -7.17 | -6.916 | 2.196 | 12.4 | 11.85 | 9.131 | 11.57 | 20.55 | 22.74 |
| Net income 1 | -31.16 | -16.25 | -19.68 | -18.84 | -10.91 | -10.07 | -7.157 | -7.567 | 1.245 | 11.13 | 9.594 | 7.701 | 10.15 | 20.4 | 22.09 |
| Net margin | -36.79% | -16.04% | -17.33% | -13.01% | -6.52% | -5.28% | -3.44% | -3.34% | 0.5% | 4% | 3.25% | 2.44% | 3.03% | 5.81% | 6.03% |
| EPS 2 | -0.1500 | -0.0800 | -0.1000 | -0.0900 | -0.0500 | -0.0500 | -0.0300 | -0.0400 | 0.0100 | 0.0500 | 0.0422 | 0.0349 | 0.0387 | 0.0886 | 0.0984 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/22/22 | 5/9/22 | 8/8/22 | 11/7/22 | 2/27/23 | 5/8/23 | 8/7/23 | 11/6/23 | 2/26/24 | 5/6/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 27.3 | 72.6 | 47.6 | 97.5 | 217 | 418 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -4.22 | -35.2 | -29.2 | 56.3 | 64.3 | 141 | - |
| ROE (net income / shareholders' equity) | - | -24.2% | -32.2% | -20.3% | -7.18% | 12.1% | 17.7% | - |
| ROA (Net income/ Total Assets) | - | - | - | -16.7% | -5.83% | 9.51% | 14.6% | - |
| Assets 1 | - | - | - | 393.5 | 403.8 | 419.6 | 470.6 | - |
| Book Value Per Share 2 | - | -1.260 | 1.790 | 1.520 | 1.640 | 1.960 | 2.720 | - |
| Cash Flow per Share 2 | - | -0.0300 | -0.1800 | -0.1300 | 0.3500 | 0.6500 | 0.8500 | - |
| Capex 1 | - | 1.74 | 0.83 | 2.71 | 17.2 | 31 | 35.9 | 65.5 |
| Capex / Sales | - | 1.17% | 0.31% | 0.52% | 1.97% | 2.53% | 2.35% | 3.55% |
| Announcement Date | 10/23/20 | 3/18/21 | 2/22/22 | 2/27/23 | 2/26/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
16.88
USD
Average target price
17.17
USD
Spread / Average Target
+1.74%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +89.66% | 3.63B | |
| -46.73% | 1.95B | |
| +78.57% | 584M | |
| +12.60% | 485M | |
| -71.02% | 128M | |
| -27.48% | 90.39M |
- Stock Market
- Equities
- HIMS Stock
- Financials Hims & Hers Health, Inc.
